ArticleJACC. Case reports2026
Contemporary Management of Valvular Cardiogenic Shock Using Transcatheter Valve Interventions.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Valvular cardiogenic shock is an under-recognized, yet potentially reversible cause of hemodynamic collapse associated with high mortality. Rapid recognition, comprehensive hemodynamic assessment, and multidisciplinary Heart Team management are critical for successful treatment. Surgical intervention is often prohibitive because of hemodynamic instability, advanced comorbidities, prior cardiac surgeries, or multiorgan dysfunction. We report a case series of patients with diverse valvular pathologies presenting with cardiogenic shock who were treated with transcatheter valve interventions, including transcatheter aortic valve replacement, transcatheter edge-to-edge repair, and balloon mitral valvuloplasty. Mechanical circulatory support was individualized according to shock phenotype and ventricular function. Although all procedures achieved technical success with immediate hemodynamic improvement, clinical outcomes varied according to the severity of underlying ventricular dysfunction, right ventricular failure, renal injury, and postcardiotomy physiology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.